Ginkgo Bioworks Holdings, Inc. financial data

Symbol
DNA on NYSE, DNABW on OTC
Location
27 Drydock Avenue, 8 Th Floor, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 505 % -7.54%
Quick Ratio 0.44 % -90.5%
Return On Equity -65.4 % +50.5%
Return On Assets -42.5 % +57.3%
Operating Margin -193 % +33.8%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 56.8M shares +7.07%
Entity Public Float 617M USD -74.6%
Common Stock, Value, Issued 6K USD +20%
Weighted Average Number of Shares Outstanding, Basic 55.6M shares +6.5%
Weighted Average Number of Shares Outstanding, Diluted 55.6M shares +6.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 181M USD -17.1%
Research and Development Expense 270M USD -41.9%
General and Administrative Expense 195M USD -30%
Operating Income (Loss) -348M USD +45.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -340M USD +47.8%
Income Tax Expense (Benefit) -519K USD -47.4%
Net Income (Loss) Attributable to Parent -80.8M USD -43.2%
Earnings Per Share, Basic -6 USD/shares +70.1%
Earnings Per Share, Diluted -6 USD/shares +70.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 111M USD -82%
Marketable Securities, Current 384M USD
Accounts Receivable, after Allowance for Credit Loss, Current 21.4M USD -8.46%
Inventory, Net 46K USD -98.9%
Other Assets, Current 362K USD -25.7%
Assets, Current 506M USD -23.6%
Property, Plant and Equipment, Net 177M USD -16.3%
Operating Lease, Right-of-Use Asset 368M USD -9.29%
Intangible Assets, Net (Excluding Goodwill) 61.5M USD -22.7%
Goodwill 0 USD -100%
Other Assets, Noncurrent 46.6M USD -22.1%
Assets 1.19B USD -19.7%
Accounts Payable, Current 10.7M USD -31.8%
Employee-related Liabilities, Current 9.89M USD -36.9%
Contract with Customer, Liability, Current 25.2M USD +10.2%
Liabilities, Current 115M USD +0.75%
Contract with Customer, Liability, Noncurrent 74.1M USD -29.6%
Operating Lease, Liability, Noncurrent 423M USD -5.1%
Other Liabilities, Noncurrent 17.2M USD -2.91%
Liabilities 629M USD -7.84%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2M USD +659%
Retained Earnings (Accumulated Deficit) -6.07B USD -5.93%
Stockholders' Equity Attributable to Parent 560M USD -29.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 613M USD -26.4%
Liabilities and Equity 1.19B USD -19.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -51.5M USD +42.3%
Net Cash Provided by (Used in) Financing Activities -207K USD +75.5%
Net Cash Provided by (Used in) Investing Activities -199M USD -1541%
Common Stock, Shares Authorized 15.8B shares 0%
Common Stock, Shares, Issued 60.3M shares +6.58%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -250M USD -145%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 157M USD -76.3%
Deferred Tax Assets, Valuation Allowance 772M USD +8.44%
Deferred Tax Assets, Gross 876M USD +13.4%
Operating Lease, Liability 467M USD +94.2%
Payments to Acquire Property, Plant, and Equipment 7.62M USD +13.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -338M USD +47.9%
Lessee, Operating Lease, Liability, to be Paid 724M USD +67.9%
Property, Plant and Equipment, Gross 359M USD -0.86%
Operating Lease, Liability, Current 28.6M USD +74.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 56.2M USD +24.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 61.2M USD +40.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 256M USD +34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 56.7M USD +43.9%
Deferred Tax Assets, Operating Loss Carryforwards 332M USD +19.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 58.4M USD +48.5%
Additional Paid in Capital 6.63B USD +1.53%
Amortization of Intangible Assets 18.8M USD +13.3%
Deferred Tax Assets, Net of Valuation Allowance 104M USD +72%
Share-based Payment Arrangement, Expense 81.1M USD -39.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%